These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
171 related articles for article (PubMed ID: 32551990)
21. Efficacy and safety of ipratropium bromide/salbutamol sulphate administered in a hydrofluoroalkane metered-dose inhaler for the treatment of COPD. Bhattacharya A; Bhargava S; Singh V; Talwar D; Whig J; Rebello J; Purandare S; Gogtay J Int J Chron Obstruct Pulmon Dis; 2016; 11():1469-76. PubMed ID: 27418820 [TBL] [Abstract][Full Text] [Related]
22. Pharmaceutical transition to non-CFC pressurized metered dose inhalers. Cripps A; Riebe M; Schulze M; Woodhouse R Respir Med; 2000 Jun; 94 Suppl B():S3-9. PubMed ID: 10919679 [TBL] [Abstract][Full Text] [Related]
23. Influence of propellant composition on drug delivery from a pressurized metered-dose inhaler. Williams RO; Repka M; Liu J Drug Dev Ind Pharm; 1998 Aug; 24(8):763-70. PubMed ID: 9876524 [TBL] [Abstract][Full Text] [Related]
24. Reduced Environmental Impact of the Reusable Respimat Hänsel M; Bambach T; Wachtel H Adv Ther; 2019 Sep; 36(9):2487-2492. PubMed ID: 31317391 [TBL] [Abstract][Full Text] [Related]
25. The Evolution of Pressurized Metered-Dose Inhalers from Early to Modern Devices. Roche N; Dekhuijzen PN J Aerosol Med Pulm Drug Deliv; 2016 Aug; 29(4):311-27. PubMed ID: 26824873 [TBL] [Abstract][Full Text] [Related]
26. Cosuspensions of microcrystals and engineered microparticles for uniform and efficient delivery of respiratory therapeutics from pressurized metered dose inhalers. Vehring R; Lechuga-Ballesteros D; Joshi V; Noga B; Dwivedi SK Langmuir; 2012 Oct; 28(42):15015-23. PubMed ID: 22985189 [TBL] [Abstract][Full Text] [Related]
27. In vitro properties of pressurized metered dose inhalers with and without spacer devices. Berg E J Aerosol Med; 1995 Sep; 8 Suppl 3():S3-10; discussion S11. PubMed ID: 10157897 [TBL] [Abstract][Full Text] [Related]
28. Computational analyses of a pressurized metered dose inhaler and a new drug-aerosol targeting methodology. Kleinstreuer C; Shi H; Zhang Z J Aerosol Med; 2007; 20(3):294-309. PubMed ID: 17894536 [TBL] [Abstract][Full Text] [Related]
29. Plume temperature emitted from metered dose inhalers. Brambilla G; Church T; Lewis D; Meakin B Int J Pharm; 2011 Feb; 405(1-2):9-15. PubMed ID: 21129465 [TBL] [Abstract][Full Text] [Related]
30. A Review of Methods for Evaluating Particle Stability in Suspension Based Pressurized Metered Dose Inhalers. D'Sa D; Chan HK Curr Pharm Des; 2015; 21(27):3955-65. PubMed ID: 26290200 [TBL] [Abstract][Full Text] [Related]
31. Double-blind, double-dummy, multinational, multicenter, parallel-group design clinical trial of clinical non-inferiority of formoterol 12 microg/unit dose in a b.i.d. regimen administered via an HFA-propellant-pMDI or a dry powder inhaler in a 12-week treatment period of moderate to severe stable persistent asthma in adult patients. Dusser D; Vicaut E; Lefrançois G; Respiration; 2005; 72 Suppl 1():20-7. PubMed ID: 15915009 [TBL] [Abstract][Full Text] [Related]
33. Drug distribution transients in solution and suspension-based pressurised metered dose inhaler sprays. Duke DJ; Scott HN; Kusangaya AJ; Kastengren AL; Matusik K; Young P; Lewis D; Honnery D Int J Pharm; 2019 Jul; 566():463-475. PubMed ID: 31173800 [TBL] [Abstract][Full Text] [Related]
35. A randomized, double-blind, double-dummy, single-dose, crossover trial evaluating the efficacy and safety profiles of two dose levels (12 and 24 microg) of formoterol-HFA (pMDI) vs. those of a dose level (24 microg) of formoterol-DPI (Foradil/Aerolizer) and of placebo (pMDI or Aerolizer) in moderate to severe asthmatic patients. Bousquet J; Guenolé E; Duvauchelle T; Vicaut E; Lefrançois G Respiration; 2005; 72 Suppl 1():13-9. PubMed ID: 15915008 [TBL] [Abstract][Full Text] [Related]
36. The chlorofluorocarbon to hydrofluoroalkane transition: the effect on pressurized metered dose inhaler suspension stability. Brindley A J Allergy Clin Immunol; 1999 Dec; 104(6):S221-6. PubMed ID: 10588978 [TBL] [Abstract][Full Text] [Related]
37. How do patients determine that their metered-dose inhaler is empty? Rubin BK; Durotoye L Chest; 2004 Oct; 126(4):1134-7. PubMed ID: 15486374 [TBL] [Abstract][Full Text] [Related]
38. Canister valve and actuator deposition in metered dose inhalers formulated with low-GWP propellants. Duke DJ; Rao L; Kastengren A; Myatt B; Cocks P; Stein S; Marasini N; Ong HX; Young P Int J Pharm; 2023 Dec; 648():123569. PubMed ID: 37925043 [TBL] [Abstract][Full Text] [Related]
39. A randomized, double-blind, double-dummy, single-dose, efficacy crossover trial comparing formoterol-HFA (pMDI) versus formoterol-DPI (Aerolizer) and placebo (pMDI or Aerolizer) in asthmatic patients. Bousquet J; Huchon G; Leclerc V; Vicaut E; Lefrançois G Respiration; 2005; 72 Suppl 1():6-12. PubMed ID: 15915007 [TBL] [Abstract][Full Text] [Related]
40. Evaluation of Disposable and Traditional Accessory Devices for Use With a Pressurized Metered-Dose Inhaler. Saeed H; Abdelrahim ME; Rabea H; Salem HF Respir Care; 2020 Mar; 65(3):320-325. PubMed ID: 31455686 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]